DOSSIER · 13F Holders · Q2 2026
RNAZ

TRANSCODE THERAPEUTICS INC

9 institutions still hold TRANSCODE THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 89357L501·9 13F holders·last filed Jun 30, 2026
Market cap
13F value held
$208K
visible holders
Holders
9
filers reporting
Concentration
58.62%
Yorkville Advisors Global, LP #1
top holder share
AI Holders Summary · Q2 2026

9 institutions reported RNAZ in Q2 2026. Yorkville Advisors Global, LP leads at 58.6% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
Yorkville Advisors Global, LP
CIK 0001838613
$122K20K0.14%Q2 2026
02
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$41K7K0.00%Q2 2026
03
VANGUARD FIDUCIARY TRUST CO
CIK 0000933478· Index
$19K3K0.00%Q2 2026
04
UBS Group AG
CIK 0001610520
$18K3K0.00%Q2 2026
05
FMR LLC
CIK 0000315066
$4K7060.00%Q2 2026
06
Tower Research Capital LLC (TRC)
CIK 0001533421
$4K6770.00%Q2 2026
07
WELLS FARGO & COMPANY/MN
CIK 0000072971
$342550.00%Q2 2026
08
SBI Securities Co., Ltd.
CIK 0001851815
$75120.00%Q2 2026
09
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
CIK 0000752798
$00Q2 2025
Insiders at TRANSCODE THERAPEUTICS INC
Manting ErikFitzgerald Thomas ACalais PhilippeMarquet MagdaDudley Robert MichaelMedarova Zdravka